Literature DB >> 18725456

Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Seisuke Kusano1, Mutsuko Kukimoto-Niino, Ryogo Akasaka, Mitsutoshi Toyama, Takaho Terada, Mikako Shirouzu, Takayuki Shindo, Shigeyuki Yokoyama.   

Abstract

Receptor activity-modifying protein (RAMP) 1 forms a heterodimer with calcitonin receptor-like receptor (CRLR) and regulates its transport to the cell surface. The CRLR.RAMP1 heterodimer functions as a specific receptor for calcitonin gene-related peptide (CGRP). Here, we report the crystal structure of the human RAMP1 extracellular domain. The RAMP1 structure is a three-helix bundle that is stabilized by three disulfide bonds. The RAMP1 residues important for cell-surface expression of the CRLR.RAMP1 heterodimer are clustered to form a hydrophobic patch on the molecular surface. The hydrophobic patch is located near the tryptophan residue essential for binding of the CGRP antagonist, BIBN4096BS. These results suggest that the hydrophobic patch participates in the interaction with CRLR and the formation of the ligand-binding pocket when it forms the CRLR.RAMP1 heterodimer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725456      PMCID: PMC2578806          DOI: 10.1110/ps.036012.108

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  34 in total

Review 1.  Receptor activity modifying proteins.

Authors:  P M Sexton; A Albiston; M Morfis; N Tilakaratne
Journal:  Cell Signal       Date:  2001-02       Impact factor: 4.315

2.  ESPript: analysis of multiple sequence alignments in PostScript.

Authors:  P Gouet; E Courcelle; D I Stuart; F Métoz
Journal:  Bioinformatics       Date:  1999-04       Impact factor: 6.937

3.  Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice.

Authors:  A M Salmon; M I Damaj; L M Marubio; M P Epping-Jordan; E Merlo-Pich; J P Changeux
Journal:  Nat Neurosci       Date:  2001-04       Impact factor: 24.884

4.  Elevated sympathetic nervous activity in mice deficient in alphaCGRP.

Authors:  Y Oh-hashi; T Shindo; Y Kurihara; T Imai; Y Wang; H Morita; Y Imai; Y Kayaba; H Nishimatsu; Y Suematsu; Y Hirata; Y Yazaki; R Nagai; T Kuwaki; H Kurihara
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

5.  Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.

Authors:  E T Zumpe; N Tilakaratne; N J Fraser; G Christopoulos; S M Foord; P M Sexton
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

6.  The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.

Authors:  K Kuwasako; K Kitamura; K Ito; T Uemura; Y Yanagita; J Kato; T Sakata; T Eto
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

7.  Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.

Authors:  H Doods; G Hallermayer; D Wu; M Entzeroth; K Rudolf; W Engel; W Eberlein
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

8.  The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.

Authors:  N J Fraser; A Wise; J Brown; L M McLatchie; M J Main; S M Foord
Journal:  Mol Pharmacol       Date:  1999-06       Impact factor: 4.436

9.  Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins.

Authors:  B Prakash; G J Praefcke; L Renault; A Wittinghofer; C Herrmann
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

10.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04
View more
  18 in total

Review 1.  Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors.

Authors:  Kuntal Pal; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

2.  Mutational and cysteine scanning analysis of the glucagon receptor N-terminal domain.

Authors:  Martine Prévost; Pascale Vertongen; Vincent Raussens; David Jonathan Roberts; Johnny Cnudde; Jason Perret; Magali Waelbroeck
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

3.  Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.

Authors:  Heather E Moad; Augen A Pioszak
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

Review 4.  Structure-function relationships of the N-terminus of receptor activity-modifying proteins.

Authors:  Tao Qi; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

5.  Quinoline derivatives: candidate drugs for a class B G-protein coupled receptor, the calcitonin gene-related peptide receptor, a cause of migraines.

Authors:  Hira Iftikhar; Iqra Ahmad; Siew H Gan; Munvar M Shaik; Naveed Iftikhar; Muhammad S Nawaz; Nigel H Greig; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

6.  Bacterial expression and purification of a heterodimeric adrenomedullin receptor extracellular domain complex using DsbC-assisted disulfide shuffling.

Authors:  Heather E Hill; Augen A Pioszak
Journal:  Protein Expr Purif       Date:  2012-12-13       Impact factor: 1.650

Review 7.  The expanding repertoire of receptor activity modifying protein (RAMP) function.

Authors:  Klara R Klein; Brooke C Matson; Kathleen M Caron
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-01-06       Impact factor: 8.250

8.  High-yield membrane protein expression from E. coli using an engineered outer membrane protein F fusion.

Authors:  Pin-Chuan Su; William Si; Deidre L Baker; Bryan W Berger
Journal:  Protein Sci       Date:  2013-02-21       Impact factor: 6.725

9.  Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.

Authors:  Philip S Miller; James Barwell; David R Poyner; Mark J Wigglesworth; Stephen L Garland; Dan Donnelly
Journal:  Biochem Biophys Res Commun       Date:  2009-11-13       Impact factor: 3.575

10.  Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor.

Authors:  James Barwell; Philip S Miller; Dan Donnelly; David R Poyner
Journal:  Peptides       Date:  2009-11-11       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.